Jason Richard Paris

1 Patent

• US120603582024

  Orally Bioavailable, Brain-penetrant Compound with Selectivity for the Cannabinoid Type 2 Receptor with Potential Use Towards Visceral Pain Management and Neurodegenerative Disorders

  0 cites